Medtronic MiniMed Infusion Pumps
Medtronic is recalling various MiniMed infusion pumps due to risks of insulin over- or under-delivery that can cause severe health complications.
Check your pump model against the affected list and monitor your blood glucose levels closely. Contact Medtronic for further instructions on safe use and potential replacement options.
Why it was recalled
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
How to identify it
UPC 763000854768 763000505196 763000505219 763000505318 763000505257 763000505295 763000505233 763000505370
MiniMed 720G Insulin Pump (MMT-1809, MMT-1810, MMT-1859, MMT-1860, MMT-1867)
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from Medtronic MiniMed, Inc.
Editorial summary by Recall Canary · last updated 2026-06-05 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification